Results 141 to 150 of about 242,018 (254)

Fixed‐Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

American Journal of Hematology, Volume 101, Issue 5, Page 986-997, May 2026.
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett, Laurie H. Sehn, Sarit Assouline, Pratyush Giri, John Kuruvilla, Stephen J. Schuster, Sung‐Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma C. Gutierrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Penuel, Vanda Teodoro, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, L. Elizabeth Budde   +20 more
wiley   +1 more source

Lymphocyte count and risk of chronic lymphocytic leukemia. [PDF]

J Natl Cancer Inst
Pahnke S, Alcala K, Bulos Salim C, Cortez Cardoso Penha R, Park HA, Mckay J, Johansson M.   +6 more
europepmc   +1 more source

Epidemiology of Cancer‐Associated Venous Thromboembolism Across the United States

American Journal of Hematology, Volume 101, Issue 5, Page 1005-1018, May 2026.
ABSTRACT Prior epidemiological studies on cancer‐associated venous thromboembolism (VTE) were limited by homogenous patient populations. We leverage Cosmos, a collaborative dataset of Epic electronic health record systems, to conduct an updated evaluation of cancer‐associated VTE in the United States (US).
Barbara D. Lam, Justine Ryu, Omid Jafari, Rock Bum Kim, Shengling Ma, Mrinal Ranjan, Jun Y. Jiang, Ang Li   +7 more
wiley   +1 more source

Progressive Rapid Atherosclerotic Plaque Formation and Early Stent re‐Stenosis in an Untreated CLL Patient; A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A 66 year‐old male with a history of hypertension and poor follow‐up for chronic lymphocytic leukemia (CLL) experienced two episodes of non‐ST elevation myocardial infarction (NSTEMI) within a 6 month period. Initial coronary angiography showed two‐vessel disease, and percutaneous coronary intervention (PCI) was performed on the left anterior ...
Mohammad Shojae, Hosseinali Rostamipour, Aref Ghanaatpisheh, Sepehr Ramezanipour, Nikta Heidari   +4 more
wiley   +1 more source

P614: NOVEL SPLICE-SITE MUTATION IN PLCG2 ASSOCIATED WITH RESISTANCE TO BTK INHIBITORS

HemaSphere, 2023
Jialei Qi, Martin Wist, Eugen Tausch, Deyan Yordanov Yosifov, Anja Schade, Xiang Gao, Rashmi Priyadharshini Dheenadayalan, Christof Schneider, Sascha Endres, Daniel Mertens, Peter Gierschik, Stephan Stilgenbauer, Billy Michael Chelliah Jebaraj   +12 more
doaj   +1 more source

Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanisms. [PDF]

Hemasphere
Mikulova A, Plesingerova H, Chorvatova M, Kebkova P, Bartosikova J, Prochazkova P, Verner J, Mulidran D, Cada S, Vondalova-Blanarova O, Kolcakova N, Loja T, Kurucova T, Hoferkova E, Tichy B, Kotaskova J, Mraz M, Kubala L, Janovska P, Bryja V.   +19 more
europepmc   +1 more source

Adverse Prognostic Significance of Activation‐Induced Cytidine Deaminase in Diffuse Large B‐Cell Lymphoma Patients Treated With R‐CHOP

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background A number of studies have demonstrated the important role of activation‐induced cytidine deaminase (AID) in the pathogenesis of diffuse large B‐cell lymphoma (DLBCL). AID has been relatively underexplored as a prognostic factor in DLBCL, and its role remains controversial.
Mardiah Suci Hardianti, Nungki Anggorowati, Syahru Agung Setiawan, Miraz Radhea Bagaskoro, Johan Kurnianda, Kartika Widayati Taroeno‐Hariadi, Ibnu Purwanto, Susanna Hilda Hutajulu   +7 more
wiley   +1 more source

B-Cell Chronic Lymphocytic Leukemia and Colon Adenocarcinoma in the Same Mesenteric Lymph Node

Turkish Journal of Hematology, 2013
Ahmet Emre Eşkazan, Selin Berk, Ferhat Özden, Sibel Erdamar, Nükhet Tüzüner, Teoman Soysal   +5 more
doaj   +1 more source

Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report. [PDF]

J Med Case Rep
Mahani FK, Nezhad NZ, Ghaderi R, Jafari E, Khazaeli M, Kermanshahaninejad SO, Shamsinejad B.   +6 more
europepmc   +1 more source

Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx

Head &Neck, Volume 48, Issue 5, Page 1311-1318, May 2026.
ABSTRACT Background University of Michigan Cancer Center (UMCC) protocol 9520 treated stage III/IV locally advanced squamous cell carcinoma of the larynx (LASCCL) with cisplatin and 5‐fluorouracil to select for definitive therapy based on response.
Zachary Risch, Emily Bellile, Moneb S. Bughrara, Paul L. Swiecicki, Keith Casper, Kelly Malloy, Norman Hogikyan, Matthew Spector, Andrew Shuman, Chaz Stucken, Steven Chinn, Douglas C. Chepeha, Shruti Jolly, Michelle Mierzwa, Carol Bradford, Avraham Eisbruch, Thomas Carey, Mark Prince, Gregory T. Wolf, Francis P. Worden   +19 more
wiley   +1 more source